Solumed Centrum Medyczne | Poznan, Poland
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The study consists of 4 sub-studies, as follows:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Participants who have entered and completed Study M16-006 or Study M15-991 or other AbbVie risankizumab Crohn's disease study.
Participants have completed the study M16-006 or M15-991 and have achieved clinical response.
Sub-Study 4:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
1,336 participants in 8 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal